Skip to content

Gene therapy restores sight in people with inherited blindness

29 Apr, 2016

Professor Robert MacLaren carrying out gene therapy at the John Radcliffe Hospital

Researchers at the University of Oxford have found gene therapy can return some sight to people with inherited blindness for up to four years after treatment. 

Scientists used gene therapy to treat people with chorideremia – a genetic disease causing progressive loss of vision, and eventually complete blindness. 

They injected a harmless virus directly into the eye to replace the gene missing in people with chorideremia. Four years after treatment, two of the six people on the trial had much better vision, and three had no deterioration in their treated eyes. 

Professor Robert MacLaren, who led the study, said this seemingly permanent effect “is the breakthrough we have all been waiting for”. 

It’s hoped gene therapy could restore sight in people with other types of inherited blindness, including retinitis pigmentosa, and age-related macular degeneration. 

Wellcome funded the study, published this week in the New England Journal of Medicine, through our Health Innovation Challenge Fund in partnership with NIHR. 

A follow on trial of 30 further patients will now take place.

Read more about the trial results in the Oxford University Hospitals NHS Foundation Trust press release




No comments yet

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: